SCHEMBL2176481

SCHEMBL2176481

COC(C(=O)N1CCCC1C(N)=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.47
RAB9A P51151 2/20 0.46
ERAP2 Q6P179 1/20 0.45
ERAP1 Q9NZ08 1/20 0.45
LNPEP Q9UIQ6 1/20 0.45
DPP4 P27487 2/20 0.44
SPHK2 Q9NRA0 1/20 0.43
SPHK1 Q9NYA1 1/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP1A2 P05177 1/20 0.43
ACE P12821 2/20 0.42
HTR1A P08908 2/20 0.42
HTR7 P34969 2/20 0.42
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KMT2A Q03164 1/20 0.42
PREP P48147 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6439008 0.90 ALDH1A1 (0.53) KCNH2ACEALDH1A1SMN1; SMN2
SCHEMBL6435766 0.90 ALDH1A1 (0.53) KCNH2ACEALDH1A1SMN1; SMN2
SCHEMBL6435771 0.90 ALDH1A1 (0.53) KCNH2ACEALDH1A1SMN1; SMN2
SCHEMBL6436515 0.90 ALDH1A1 (0.53) KCNH2ACEALDH1A1SMN1; SMN2
SCHEMBL6436519 0.90 ALDH1A1 (0.53) KCNH2ACEALDH1A1SMN1; SMN2
SCHEMBL16508651 0.88 KCNH2 (0.47) KCNH2RAB9ADPP4CYP3A4CYP2D6
SCHEMBL14664118 0.85 RAB9A (0.47) KCNH2RAB9ADPP4CYP3A4CYP2D6
SCHEMBL2355316 0.83 SCN9A (0.52) KCNH2RAB9ADPP4HTR1AHTR7
SCHEMBL6980126 0.82 AGTR2 (0.52) DPP4
SCHEMBL13570514 0.81 F2 (0.53) RAB9AERAP2ERAP1LNPEPDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519506-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-11-07 EP claimed
WO-2011082077-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-07-07 WO claimed